Form 4: Delcath Systems Director Awarded Stock Options

Bridget A. Martell, a director of Delcath Systems, Inc., was granted stock options to purchase 22,500 shares of common stock on May 15, 2025.

Summary

• On May 15, 2025, Bridget A. Martell, a director of Delcath Systems, Inc., received stock options.
• These options allow her to purchase 22,500 shares of Delcath Systems common stock at an exercise price of $16.05 per share.
• The options vest monthly, starting May 15, 2025, at a rate of one-twelfth per month, contingent on her continued service as a director.
• The options expire 10 years from the grant date or two years after her last day of service, whichever comes first, for vested options.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine grant of stock options to a director, which is generally viewed as a positive incentive but doesn't necessarily indicate a significant shift in the company's prospects.

Positives

• The granting of stock options to a director aligns her interests with those of the shareholders, incentivizing her to work towards the company's success.
• The monthly vesting schedule encourages continued service and commitment from the director.

Industry Context

Stock option grants are a common practice in the biotechnology industry to attract and retain qualified board members and align their interests with those of shareholders.

Comparison to Industry Standards

• Stock option grants to directors are a standard practice across publicly traded companies, particularly in the biotech sector.
• The size of the grant (22,500 shares) and the vesting schedule (monthly over one year) would need to be compared to similar companies of Delcath's size and stage to determine if it is in line with industry norms.
• Companies like Exact Sciences or Novocure, which are in a similar market capitalization range, could be used as benchmarks for comparison.

Stakeholder Impact

• Shareholders may view the option grant as a positive incentive for the director.
• The director is incentivized to increase shareholder value through her role.

Key Dates

Keywords

stock options, Delcath Systems, director, Bridget A. Martell, equity incentive, Form 4